These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6684643)

  • 1. IgE in leprosy; effect of a Mycobacterium leprae-BCG vaccine.
    Lynch NR; Lopez RI; Ulrich M; Aranzazu N; Convit J
    Int J Lepr Other Mycobact Dis; 1983 Jun; 51(2):169-73. PubMed ID: 6684643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte transformation in lepromatous leprosy: a study of the influence of disease activity and symptom duration.
    Brown AE; Vithayasai V; Scollard DM; Nelson KE; Moses V; Schauf V; Makonkawkeyoon S
    Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):104-10. PubMed ID: 3738597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic aspects of leprosy with special reference to the study of immunoglobulin E.
    Saha K; Dutta RN; Dasgupta A
    Int J Lepr Other Mycobact Dis; 1975; 43(4):314-9. PubMed ID: 1241687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum CCL2 concomitant with a reduced mycobacterium-induced response leads to disease dissemination in leprosy.
    Hasan Z; Jamil B; Zaidi I; Zafar S; Khan AA; Hussain R
    Scand J Immunol; 2006 Mar; 63(3):241-7. PubMed ID: 16499578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of BCG against leprosy and its subtypes: a case-control study in southern Vietnam.
    Thuc NV; Abel L; Lap VD; Oberti J; Lagrange PH
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):532-8. PubMed ID: 7868950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):434-43. PubMed ID: 11332286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Borderline tuberculoid leprosy following BCG vaccination. A case report.
    Stoner GL; Belehu A; Nsibambi J; Warndorff J
    Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):16-20. PubMed ID: 7195879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG subclass antibody to Mycobacterium leprae 18,000 MW antigen is restricted to IgG1 and IgG3 in leprosy.
    Hussain R; Dockrell HM; Chiang TJ
    Immunology; 1994 Nov; 83(3):495-500. PubMed ID: 7835976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents.
    Hussain R; Shahid F; Zafar S; Dojki M; Dockrell HM
    Immunology; 2004 Apr; 111(4):462-71. PubMed ID: 15056384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA, IgM and IgG anti-M. leprae antibodies in babies of leprosy mothers during the first 2 years of life.
    Melsom R; Harboe M; Duncan ME
    Clin Exp Immunol; 1982 Sep; 49(3):532-42. PubMed ID: 6756719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda-negative contacts.
    Convit J; Aranzazu N; Ulrich M; Pinardi ME; Reyes O; Alvarado J
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):415-24. PubMed ID: 6763002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):27-39. PubMed ID: 10834067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
    Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
    Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
    Smelt AH; Rees RH; Liew FY
    Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.